January 24, 2018 / 7:40 AM / 3 months ago

BRIEF-Faron Pharmaceuticals Says ‍U.S. FDA Approved Investigational NDA For Traumakine

Reuters Staff

1 Min Read

Jan 24 (Reuters) - Faron Pharmaceuticals Oy:

* ‍US FOOD AND DRUG ADMINISTRATION HAS APPROVED INVESTIGATIONAL NEW DRUG APPLICATION FOR TRAUMAKINE Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 80 6749 1136)

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

BRIEF-Faron Pharmaceuticals Says ‍U.S. FDA Approved Investigational NDA For Traumakine​

BRIEF-Faron Pharmaceuticals Says ‍U.S. FDA Approved Investigational NDA For Traumakine